Novel anthracene-9-sulfonyl derivatives as anticancer agents: synthesis and in vitro biological evaluation
Last updated: 01 Jan 2025
10.21608/ejchem.2020.24843.2473
anthracene, 9, sulfonyl. Anticancer. HCT, 116 cells. HepG 2 cells. MCF, 7 cells
Walaa
Salah Goda Elserwy
Pharmaceutical Industries Research division Therapeutical Chemistry Department National Research Centre
walaasalah16@yahoo.com
0000-0002-0400-4637
neama
mohammed
2Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo, Egypt, 12622.
neamanrc@yahoo.com
0000-0003-1221-9926
Emad
Kassem
Department of Therapeutic Chemistry, National Research Centre, Dokki 12622, Giza, Egypt,
emadkassem@hotmail.com
Marwa
Mounier
Pharmaceutical and Drug Industries Research Division, Department of Pharmacognosy, National Research Centre, Giza, Egypt
marwa_m3@yahoo.com
Weam
Salah Goda Elserwy
Department Of Microbial and Natural Products chemistry National Research Centre
awab_13@yahoo.com
0000-0003-1757-1742
63
11
18119
2020-11-01
2020-02-28
2020-11-01
4,217
4,225
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_78942.html
https://ejchem.journals.ekb.eg/service?article_code=78942
6
Original Article
297
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
Novel anthracene-9-sulfonyl derivatives as anticancer agents: synthesis and in vitro biological evaluation
Details
Type
Article
Created At
22 Jan 2023